For the first time, pharmaceutical companies are beginning to invest significantly in the drive to create new treatments based on embryonic and adult stem cells.
http://reports.pr-inside.com/stem-cells-the-hype-and-r3516048.htm
http://reports.pr-inside.com/stem-cells-the-hype-and-r3516048.htm
No comments:
Post a Comment